ArticleScientific reports2016

Co-targeting EGFR and survivin with a bivalent aptamer-dual siRNA chimera effectively suppresses prostate cancer.

Hong Yan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.